Biologic Medications and Cancer Risk
There has been some speculation on whether or not biologic medications can increase a patient’s risk of getting cancer in the long run. Dr. Laura Cappelli from the Arthritis Center discusses these risks as well as the research studies behind them.
In This Video
Dr. Cappelli is an Assistant Professor of Medicine in the Johns Hopkins Division of Rheumatology. Her research focuses on inflammatory arthritis and on the effects of cancer immunotherapy.